Publications by authors named "Dowdy Jackson"

Claim this Profile
U
Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates.
Dowdy Jackson, David Stover

Pharm Res· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates.
Dowdy Jackson, John Atkinson, Claudia I Guevara, Chunying Zhang, Vladimir Kery

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma.
Jeong-Won Lee, Rebecca L Stone, Sun Joo Lee, Eun Ji Nam, Ju-Won Roh, Dowdy Jackson

Clin Cancer Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy.
Guanglei Zhuang, Dana M Brantley-Sieders, David Vaught, Jian Yu, Lu Xie, Dowdy Jackson

Cancer Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.
Jeong-Won Lee, Hee Dong Han, Mian M K Shahzad, Seung Wook Kim, Lingegowda S Mangala, Dowdy Jackson

J Natl Cancer Inst· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib.
Ching Ching Leow, Jon Chesebrough, Karen T Coffman, Christine A Fazenbaker, John Gooya, Dowdy Jackson

Mol Cancer Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.
Dowdy Jackson, John Gooya, Shenlan Mao, Krista Kinneer, Linda Xu

Cancer Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
Dana M Brantley-Sieders, Guanglei Zhuang, Donna Hicks, Wei Bin Fang, Yoonha Hwang, Dowdy Jackson

J Clin Invest· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis.
Dmitri Wiederschain, Lin Chen, Brett Johnson, Kimberly Bettano, Dowdy Jackson

Mol Cell Biol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
Qing Shi, Anita B Hjelmeland, Stephen T Keir, Linhua Song, Sarah Wickman, Dowdy Jackson

Mol Carcinog· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo.
Ta-Jen Liu, Tiffany LaFortune, Toshiyuki Honda, Osamu Ohmori, Shinji Hatakeyama, Dowdy Jackson

Mol Cancer Ther· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors.
Nikki Cheng, Dana Brantley, Wei Bin Fang, Hua Liu, William Fanslow, Dowdy Jackson

Neoplasia· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.
Dana M Brantley, Nikki Cheng, Erin J Thompson, Qing Lin, Rolf A Brekken, Dowdy Jackson

Oncogene· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis